These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 2182538)

  • 1. Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines.
    Levitz SM; Farrell TP
    Infect Immun; 1990 May; 58(5):1201-9. PubMed ID: 2182538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans.
    Levitz SM; DiBenedetto DJ
    Infect Immun; 1988 Oct; 56(10):2544-51. PubMed ID: 3138176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo.
    Rachini A; Pietrella D; Lupo P; Torosantucci A; Chiani P; Bromuro C; Proietti C; Bistoni F; Cassone A; Vecchiarelli A
    Infect Immun; 2007 Nov; 75(11):5085-94. PubMed ID: 17606600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin.
    Levitz SM; Tabuni A
    J Clin Invest; 1991 Feb; 87(2):528-35. PubMed ID: 1991837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form.
    Cross CE; Bancroft GJ
    Infect Immun; 1995 Jul; 63(7):2604-11. PubMed ID: 7790075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.
    Kozel TR; Follette JL
    Infect Immun; 1981 Mar; 31(3):978-84. PubMed ID: 7014468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages.
    Bolaños B; Mitchell TG
    J Med Vet Mycol; 1989; 27(4):203-17. PubMed ID: 2677298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans.
    Flesch IE; Schwamberger G; Kaufmann SH
    J Immunol; 1989 May; 142(9):3219-24. PubMed ID: 2496162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.
    Chen GH; Curtis JL; Mody CH; Christensen PJ; Armstrong LR; Toews GB
    J Immunol; 1994 Jan; 152(2):724-34. PubMed ID: 8283047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages.
    Vecchiarelli A; Pietrella D; Dottorini M; Monari C; Retini C; Todisco T; Bistoni F
    Clin Exp Immunol; 1994 Nov; 98(2):217-23. PubMed ID: 7955525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans.
    Levitz SM; Dupont MP; Smail EH
    Infect Immun; 1994 Jan; 62(1):194-202. PubMed ID: 8262627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing of Cryptococcus neoformans by human peripheral blood mononuclear cells stimulated in culture.
    Levitz SM; Farrell TP; Maziarz RT
    J Infect Dis; 1991 May; 163(5):1108-13. PubMed ID: 2019758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils.
    Kozel TR; Highison B; Stratton CJ
    Infect Immun; 1984 Feb; 43(2):574-9. PubMed ID: 6363293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans.
    Cross CE; Collins HL; Bancroft GJ
    Immunology; 1997 Jun; 91(2):289-96. PubMed ID: 9227330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody.
    Miller MF; Mitchell TG; Storkus WJ; Dawson JR
    Infect Immun; 1990 Mar; 58(3):639-45. PubMed ID: 2407651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages.
    Kozel TR; McGaw TG
    Infect Immun; 1979 Jul; 25(1):255-61. PubMed ID: 383614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
    Levitz SM; DiBenedetto DJ
    J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.
    Kozel TR; Gotschlich EC
    J Immunol; 1982 Oct; 129(4):1675-80. PubMed ID: 7050244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum.
    Bolaños B; Mitchell TG
    J Leukoc Biol; 1989 Dec; 46(6):521-8. PubMed ID: 2681492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1q enhances the phagocytosis of Cryptococcus neoformans blastospores by human monocytes.
    Bobak DA; Washburn RG; Frank MM
    J Immunol; 1988 Jul; 141(2):592-7. PubMed ID: 3290342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.